187P Effectiveness, safety, and patterns of use of camrelizumab in advanced esophageal cancer: An individual patient data (IPD) pooled analysis of 987 patients from three prospective observational cohort studies
Year: 2024
Type: article
Source: Annals of Oncology
Institutions: Peking University Cancer Hospital, Changzhi Medical College, First Affiliated Hospital of Bengbu Medical College, University of Science and Technology of China, Anhui Provincial Hospital, Shandong University, Shandong Provincial Hospital, Second Affiliated Hospital of Anhui Medical University, Anyang Tumor Hospital, Shandong Tumor Hospital, Shanxi Medical University, First Hospital of Shanxi Medical University, Hubei Cancer Hospital, Huazhong University of Science and Technology, First Affiliated Hospital of Xinxiang Medical University, Wannan Medical College, First Affiliated Hospital of Wannan Medical College, Third Affiliated Hospital of Harbin Medical University, Ganzhou People's Hospital, Fujian Medical University, Fujian Provincial Cancer Hospital, First Affiliated Hospital of Anhui Medical University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Shandong University, Harbin Medical University, Anhui Medical University, Huazhong University of Science and Technology, Tongji University, Bengbu Medical College, Peking University, Shanxi Medical University, University of Science and Technology of China, Xinxiang Medical University, Wannan Medical College, Tongji Medical College, Huazhong University of Science and Technology
OpenAlex ID: W4405134798